Deputy Director, Missouri Technology Corporation
State of Missouri
The Missouri Technology Corporation (MTC) is a public-private partnership created by the Missouri General Assembly to promote entrepreneurship and foster the growth of new and emerging high-tech companies. MTC focuses on 21st Century bioscience industries that build on Missouri’s rich history in agriculture.
Dr. Baker is senior counsel in the Intellectual Property (IP) department of Husch Blackwell, LLP. He is a registered patent attorney with degrees in chemical engineering and veterinary medicine. His practice focuses on patents and trademarks, with a particular emphasis in counseling clients with respect to IP portfolio strategy and management, research and business strategy and IP commercialization. His professional experience includes representing clients in technical matters before the US Patent Office and Federal Courts, serving as general patent counsel for Microban International, Ltd, and private veterinary practice. Dr. Baker is licensed to practice veterinary medicine in the State of Arkansas.
President & CEO, Centaur Animal Health
Olathe, Kansas and Philadelphia, Pennsylvania
Jeff is a serial entrepreneur and investor with over 30 years of global life sciences experience. Jeff’s emerging company and fund raising experience includes startups, growth stage and turnaround in pharmaceuticals, biotechnology, drug delivery, medical devices, and clinical informatics. He is a Business Advisor to university investigators seeking early stage funding from the University City Science Center in Philadelphia. He is Chairman of ProteaPex Therapeutics focused on innovative animal health peptide therapeutics. Most recently he was President and CEO of the Center for Animal Health Innovation which focused on funding breakthrough technologies.
Jane is an animal health pharmaceutical industry executive with 25+ years experience working with multinational and small companies in Asia, the USA, Australia and New Zealand. She is the author of more than 35 publications in peer reviewed journals and has an established track record in global pharmaceutical product development, departmental restructuring/relocation and staff management, Asian R&D unit start up operations, outsourcing and business development. Her major achievements include development of global pharmaceutical products, including 5 new chemical entities, from Phase I to final regulatory approval and commercialization. Jane currently works as an independent consultant providing advice and assistance to companies evaluating and developing animal health products for the USA and other markets.
Ronald Meeusen, PhD
Founding Partner, Cultivian Sandbox Food and Ag Funds I & II
Ron is a founding partner of the Cultivian Sandbox Food and Ag Funds I and II. Ron has over 30 years of experience in bringing new technologies and products to market. He has led research and development for major corporation in agricultural chemicals, field crop and vegetable genetics and breeding, animal health, novel foods and industrial materials. His successful projects include the world’s first field trial of a genetically engineered crop trait in 1986, development and launch of one of the first insect and herbicide resistant corn hybrids in 1996, introduction of a trans-fat free canola oil, and development of dozens of new varieties of field and vegetable crops on three continents. Ron has been a frequent speaker at conferences, a consultant to Federal policy on biotechnology regulatory issues, and active in industry trade groups. Prior to forming Cultivian Ron led the expansion of the biotechnology research and development program of Dow AgroSciences, and founded a successful biopharmaceutical company, Immuneworks, Inc. Ron represents Cultivian on the board of directors of Allylix, Aratana, Proterro and Rivertop Renewables. He was also a member of the board of directors of Divergence, Inc. Divergence was sold to Monsanto Company in February of 2011. Ron holds a Ph.D. from the University of California, Berkeley in plant cell biology, and a bachelor’s degree from the University of Wisconsin, Milwaukee in plant physiology.
Animalytix® LLC is an animal health business intelligence company and the leading provider of geo-located sales information. Animalytix sources its sales data from the leading animal health distributors, veterinarians and retailers and processes more than 20 million sales transactions per year to more than 145,000 veterinarians, retailers and livestock production companies. The company maintains a comprehensive database of more than $15 billion in sales history on 15,000+ products from more than 500 manufacturers. Each month, Animalytix publishes a series of syndicated and customized market surveys covering 16 unique animal health market segments and provides additional analytical support through a team of Senior Business Advisors, each former operators from the animal health manufacturing or distribution industries.
Shuler Consulting Services is focused on working with companies in the area of innovation, planning and execution. SCS has more than 30 years of experience in creating and building successful businesses and developing a strong market position for their products and services. Rich Shuler has worked with businesses, producer organizations, churches and universities to develop long range strategic plans and organizational structure. SCS also assists businesses in acquiring products and technologies that fit the company’s strategic focus.
Director of Commercialization, Kansas Bioscience Authority
State of Kansas
The Kansas Bioscience Authority (KBA) was created by the Kansas Economic Growth Act of 2004 with the sole purpose of advancing Kansas’ leadership in bioscience. The KBA is the state’s largest-ever commitment to expanding Kansas’ research capabilities, promoting innovation, and encouraging company formation that will create high-paying jobs for generations to come.